Renal Cancer
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
August 4, 2023
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study.
August 3, 2023
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
August 2, 2023
The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma.
July 31, 2023
A reactive oxygen species-related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma.
July 28, 2023
Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated Tumors.
July 27, 2023